Skip to main content
Download PDF

Genomic characterization of multi drug resistant ESBL-producing Escherichia coli isolates from patients and patient environments in a teaching hospital in Ghana

BMC Microbiology volume 24, Article number: 250 (2024) Cite this article

Abstract

Background

ESBL-producing Escherichia coli pose a growing health risk in community and healthcare settings. We investigated the resistome, virulome, mobilome, and genetic relatedness of multidrug-resistant (MDR) E. coli isolates from patients and their environment in a Ghanaian teaching hospital.

Materials and methods

Twenty-three MDR ESBL-producing or carbapenem-resistant E. coli isolates from a collection of MDR Gram-negative bacteria (GNB) from patients and environments were selected for genomic analyses. Whole genome sequencing and bioinformatics tools were used to analyze genomic characteristics and phylogeny.

Results

The prevalence and incidence of rectal carriage of ESBL E. coli among patients were 13.65% and 11.32% respectively. The β-lactamase genes, blaTEM−1B (10 isolates) and blaCTX−M−15 (12 isolates) were commonly associated with IncFIB plasmid replicons and co-occurred with aminoglycoside, macrolide, and sulfamethoxazole/trimethoprim resistance. Insertion sequences, transposons, and class I integrons were found with blaCTX−M−15. Carriage and environmental isolates carried multiple virulence genes, with terC being the most prevalent in 21 isolates. Seventeen sequence types (STs) were identified, including a novel ST (ST13846). Phylogenetic analysis grouped the isolates into four main clusters, with one outlier. High genetic relatedness was observed between two carriage isolates of ST940 and between a carriage isolate and an environmental isolate of ST648. Isolates with different STs, collected at different times and locations, also showed genetic similarities.

Conclusion

We identified ESBL-producing E. coli with diverse genomic characteristics circulating in different hospital directorates. Clonal relatedness was observed among isolates from patients and the environment, as well as between different patients, suggesting transmission within and between sources.

Peer Review reports

Introduction

In low- middle income (LMIC) countries, antimicrobial resistance is a problem leading to high death rates and is further exacerbated by the sub-optimal surveillance and poor infection prevention and control practices [1]. Multi-drug resistant Gram-negative bacteria (MDR GNB) have been implicated in critical infections in clinical settings [2].

Escherichia coli has the ability to colonize and persist in hosts and in the environment [3]. Hospitalised patients may harbour E. coli obtained from the community or acquire it after admission from various sources including the hospital environment via healthcare workers hands or being in close contact with other patients habouring resistant isolates or by touching contaminated surfaces [4, 5]. E. coli isolates may carry a repertoire of resistance and virulence genes carried on mobile genetic elements (MGEs). These MGEs include plasmids, integrons and insertion sequences which may be exchanged by horizontal gene transfer [6,7,8].

Extended spectrum β-lactamase (ESBL)–producing Escherichia coli which cause critical infections such as pneumonia and bloodstream infections are listed among the WHO priority organisms for which new antibiotics are required [9]. Colonization by antibiotic resistant organisms usually precedes infections with the same organisms thus the intestinal carriage of ESBL E. coli is a threat to health as infections caused by these result in poor treatment outcomes and high mortalities, especially among high-risk patients [5, 10]. It is estimated that globally, between 2003 and 2018, the cumulative global pooled prevalence of ESBL E. coli intestinal carriage in the community was 16.5% [5]. Colonization of hospital patients with ESBL producing E. coli isolates have been reported in African countries such as South Africa and Tanzania [11, 12]. Recent studies in a Ghanaian hospital reported that about 13.2% of diarrhoegenic E. coli isolates from patients were ESBL positive and cefotaxime resistant ESBL E. coli was found to be widely disseminated in Ghanaian hospitals [13, 14].

Patients may be colonized on admission to hospitals and could be a potential source of transfer to other patients who could become infected in hospitals [10]. Resistance and virulence genes of ESBL E. coli isolates from patients could be shed into the hospital environment through the skin, respiratory or intestinal tract and further transferred to other patients in hospitals.

E. coli isolates showing varying resistance to β-lactams have been studied in clinical settings in Ghana but most of these have been isolates from infected patients with limited studies on the molecular epidemiology of these MDR E. coli isolates. There are also limited studies on colonization with ESBL E. coli and their potential transmission to other patients and environment, particularly in non-outbreak settings. We investigated the molecular epidemiology of MDR ESBL-producing E. coli colonizing patients, carried on healthcare workers hands and contaminating selected ward and intensive care unit (ICU) environments. This was done to inform infection prevention and control (IPC) measures so as to control their spread in clinical settings.

Materials and methods

Study setting

This study was conducted at the Komfo Anokye Teaching hospital (KATH) which is 1200 - bed capacity government tertiary facility which serves as a referral hospital responding to the healthcare needs of about 80% of both emergencies and regular medical cases in the Ashanti region of Ghana that has a population of about 5.4 million. The hospital also attends to referral cases from other regions including the Bono, Bono East, Ahafo, Western and Eastern regions as well as some parts of the Northern regions of the country. This study was conducted in three directorates; Obstetrics and Gynaecology, Surgery and the Intensive Care Unit (ICU).

Sample collection

Samples were collected from consenting patients admitted to the ICU and Surgery, and Obstetrics and Gynaecology directorates of the hospital. Rectal swabs and hand swabs were aseptically collected from in-patients > 18 years old, at admission and after 48 h as previously described in the preceding study. Isolation of Gram-negative bacteria and antibiotic susceptibility testing was carried out as previously described [15].

DNA extraction and whole genome sequencing

All MDR ESBL- producing or carbapenem resistant E. coli isolates were subjected to genomic DNA (gDNA) extraction using the GenElute® bacterial genomic DNA kit (Sigma-Aldrich, St. Louis, MO, United States) according to the manufacturer’s instructions. ESBL-E. coli were defined as isolates with phenotypic resistance to at least one the third generation cephalosporins on VITEK. The quantity and quality of the extracted gDNA were determined using a Nanodrop spectrophotometer Qubit (Thermo Scientific, Waltham, MA, USA). Multiplexed paired-end libraries (2 × 300 bp) were prepared using the Nextera XT DNA sample preparation kit (Illumina, San Diego, CA, United States), and sequences were determined on an Illumina Nextseq 550 (2 × 150 bp) platform with 100× coverage.

Genomic analyses and annotation

Quality trimming of raw reads was done using Sickle v1.33 (https://github.com/najoshi/sickle). The raw reads were then assembled spontaneously using the SPAdes v3.6.2 assembler (https://cab.spbu.ru/software/spades/). All contiguous sequences were subsequently submitted to GenBank and assigned accession numbers under BioProject PRJNA823741 (Supplementary Table S1).

Multilocus sequence typing (MLST) of assembled genomes was determined on the MLST 1.8 database hosted by the Center for Genomic Epidemiology (CGE) (https://cge.food.dtu.dk/services/MLST/). Isolates with unknown STs were submitted to the EnteroBase Escherichia/Shigella database (https://enterobase.warwick.ac.uk/species/index/ecoli) and assigned novel STs. Resistance and virulence genes were determined using ResFinder (https://cge.food.dtu.dk/services/ResFinder/) and Virulence finder (https://cge.food.dtu.dk/services/VirulenceFinder/), and plasmids by PlasmidFinder 2.1 hosted on https://cge.food.dtu.dk/services. INTEGRALL (http://integrall.bio.ua.pt/) and RAST SEEDVIEWER (https://rast.nmpdr.org/seedviewer.cgi) were used to find integrons and transposons. Insertion sequences, and prophages were determined using ISFinder (https://isfinder.biotoul.fr/) and PHASTER (https://phaster.ca/), respectively. Plasmids of the IncF, IncH1, IncH2, IncI1, IncN, or IncA/C types were subtyped by assigning a replicon allele at the plasmid MLST site (https://pubmlst.org/plasmid/). Phylogroups were determined via ClermonTyper (http://clermontyping.iame-research.center/).

The synteny and genetic environment of antibiotic resistance genes (ARGs) and associated MGEs was investigated using GenBank’s general feature format (GFF3) files. The genetic environment of virulence genes detected in the study was also determined using a similar approach.

Phylogenomics

Phylogenomic analysis was undertaken to determine how the study isolates compare to E. coli genomes of human origin from South Africa and West African countries including Togo, Nigeria, Niger, Mali, Ghana, and Cameroon. All the E. coli genomes were reported in these countries from 2013 to 2021 (n = 157). The genomes were downloaded from the Bacterial and Viral Bioinformatics Resource Center (BV-BRCB) website (https://www.bv-brc.org/), annotated (Table S1), and included in the analysis. The phylogenetic tree was constructed based on the maximum likelihood method using BV-BRCB. The Escherichia coli K12-MG1655 was used as the outgroup strain (reference genome), facilitating the configuration of the phylogenetic distance between the isolates on the branches. The Figtree software (https://tree.bio.ed.ac.uk/software/figtree/) and iTOL (https://itol.embl.de/) were used to visualize, edit, and annotate the generated phylogenetic tree.

Phandango (https://jameshadfield.github.io/phandango/#/main), was used to visualise the phylogenetic tree with corresponding metadata to get a more comprehensive insight on the relationships of the isolates.

Results

Isolate characteristics

ESBL E. coli was isolated from 17 patients. Eleven of 83 (13.25%) patients were colonized with ESBL E. coli on admission. ESBL E. coli was also isolated from a patient’s hand on admission. Six of 53 (11.32%) patients who had samples taken after 48 h of admission, had acquired ESBL E. coli. Of the 208 environmental samples taken, seven (3.37%) were contaminated with ESBL E. coli. None of the healthcare workers (HCW’s) hands were contaminated with ESBL E. coli. Of the seven environmental samples with ESBL E. coli, four were isolated from beds, two from taps and one from a dripstand.

Twenty-three MDR E. coli isolates which were both MDR and ESBL-producing (21 isolates) or MDR carbapenem resistant (two isolates) E. coli isolates were subjected to WGS. Sixteen were from patients, and seven were from the hospital environment. All the carriage E. coli isolates were obtained from rectal swabs except one that was obtained from a hand swab. No isolates were obtained from healthcare workers’ hands. Three of the environmental isolates were obtained from the surgical ward, and the remaining from the obstetrics and gynaecology ward (Table 1).

Antimicrobial susceptibility of studied isolates

All of the MDR E. coli isolates selected were susceptible to amikacin, imipenem, and tigecycline. Highest resistance was observed against ampicillin (100%), sulphamethoxazole/trimethoprim (21/23, 91.3%), ceftazidime (21/23, 91.3%), cefuroxime (20/23, 87%), amoxicillin/clavulanic (21/23, 91.3%). Ten (23.3%) of the isolates were resistant to the carbapenems; doripenem, ertapenem and meropenem. Six isolates from patients and four from hospital environment were resistant to ciprofloxacin. A total of nine resistance profiles were observed across the 23 selected E. coli isolates. The most common resistance pattern (AMP-CXM-CAZ-CRO-FEP-GEN-TOB-AMC-TZP-CIP-SXT) was observed among nine E. coli isolates (five from the hospital environment and four from patients) (Table 1) suggesting the contamination of environmental surfaces with isolates of similar resistant patterns as those colonizing patients.

Antibiotic resistance genes

The resistance genotypes corresponded to the phenotypic resistance in most of the isolates except for a few isolates where there were no identified genotypes corresponding to phenotypic resistance to antibiotics. In one isolate (P165) from a patient, there were no antibiotic resistance genes corresponding to its phenotypic resistance to AMP-CXM-CAZ-CRO-FEP-GEN-TOB-AMC-TZP-CIP-SXT.

ESBL genes were identified in 19 of the 23 isolates and mostly belonged to the CTX-M and TEM classes. The most common ESBL identified among the E. coli isolates was blaCTX−M−15 harboured by 11 isolates from patients and one environmental isolate. The blaTEM−104 and blaTEM−169 genes were each harboured by E. coli from a patient. The β-lactamase blaOXA−1 was detected in 12 isolates (nine carriage and three environmental isolates). The blaTEM−1B gene was also detected in 10 isolates. The carbapenemase gene blaOXA−181 was detected in two isolates from patients. In one isolate (P2R), blaOXA−181 was detected even though there was no phenotypic expression of carbapenem resistance.

An environmental isolate, (E50-1) which showed phenotypic resistance to doripenem and meropenem had no carbapenemase or β-lactamase genes. Another isolate (P17) from a patient, harboured thirteen ESBLs (blaCTX−M−22,blaCTX−M−216, blaCTX−M−103, blaCTX−M−176, blaCTX−M−15,blaCTX−M−156, blaCTX−M−3, blaCTX−M−202, blaCTX−M−88, blaCTX−M−203, blaCTX−M−71, blaCTX−M−167, and blaOXA−1). The blaTEM−1B and blaCTX−M−15 genes commonly occurred with sulphamethoxazole and trimethoprim-resistant genes sul2 and dfrA17, respectively (Table 1).

Genes conferring resistance to aminoglycosides (aadA1, aadA2, aadA5, aph(6)-Id, aac(6’)-Ib-cr, aph(3’’)-Ib, aac(3)-IId), macrolides (mphA and ermB), tetracycline (tetA, tetB, tetL and tetM), sulphamethoxazole (sul1, sul2, sul3) and trimethoprim (dfrA1, dfrA7, dfrA12, dfrA14, dfrA17 and dfrG) were also identified in both patient and environmental isolates. The plasmid-mediated quinolone resistant (PMQR) genes, aac(6’)-Ib-cr, qnrS1, qnrB19, qnrB4 and qepA4 were also detected in the isolates. The quaternary ammonium compound resistance genes, qacE, were found in eight isolates (seven from patients and one from environmental isolates).

Reduced susceptibility to ciprofloxacin was observed in 10 isolates (six carriage isolates and four environmental isolates), therefore, mutations in the quinolone resistance determinant regions (QRDRs) DNA gyrase (gyrA and gyrB) and DNA topoisomerase IV (parC and parE) genes in the isolates from patients and environments were investigated. Mutations were commonly found in gyrA (S83L, D87N, A828S, D678E, A863V) and parC (E62K, S801, D475E, S80I, L440R) genes, with gyrB (S492N, A618T, E656D, E703D) and parE (T172A, S458A) having the least number of mutations. These mutations were commonly associated with other Plasmid mediated quinolone resistance (PMQR) determinants such as qnr. Nine isolates (four from environment and five from patients) had common mutations in gyr A (S83L, D87N), parC (S80I) and parE (S458A). One isolate (P51B) from a patient had mutations in all four genes: gyrA (S83L, D87N, A828S, D678E), gyrB (S492N, A618T, E656D), parC (E62K, S801, D475E) and parE (T172A, S458A)(Table S3).

Table 1 Source, antibiograms, sequence types (STs), phylogroups, resistance genes, virulence genes and plasmids found in the Escherichia coli isolates
Full size table

Mobilome (plasmids, insertion sequences, intact prophages, and integrons)

Plasmid analysis revealed that all but one isolate harboured plasmid replicons. Nineteen different replicons were found in the 23 isolates. InCFIB was the most frequently found replicon and was common to 11 isolates from patients and six from environment. The IncFIA, IncFIB, IncFII plasmid replicons were found together in twelve isolates: eight in patient isolates and four in environmental isolates. Two isolates from patients and one from the environment harboured up to seven different replicons.

The CTX-M-15 gene in both patients and environmental isolates was consistently associated with an insertion sequence of the IS380 family and a transposon, commonly Tn3, while the blaTEM gene was carried mainly by transposons. The disinfectant resistant gene, qacE, which was found in six isolates from patients (n = 5) and environmental isolates (n = 1), was co-carried with sul1 usually on a class 1 integron in all the isolates. Isolate P128, was found to have CTX-M-15 genes flanked by several transposons, insertion sequences and a recombinase and also harboured TEM-1, qnrS1, aph(6)-Id:aph(3’’)-Ib and sul2. The contig harbouring the CTX-M-15 gene in P128 showed high similarity of 99.98% to the E. coli strain PGR46 plasmid pPGRT46 (KM023153.1) The blaOXA−1 gene which was commonly flanked by the chloramphenicol resistant gene, catB-3 and the aminoglycoside hydrolyzing gene, aac(6’)-Ib-cr5 was not associated with transposons or insertion sequences. However, the contig harbouring the blaOXA−1 gene showed, showed high similarity to a plasmid, pBL12EC-2 (Supplementary table S5).

Investigation of MGEs which mobilize and transfer resistance genes between isolates revealed the presence of diverse MGEs in the isolates.

Many of the contigs of the E. coli isolates harbouring ARGs showed high similarity (98-100%) to plasmids in GenBank, confirming that most of the ARGs from both patients and environment are mobilized and disseminated by plasmids (Supplementary table S5).

Since prophages are known to be associated with pathogenicity factors, the types of prophages in the isolates were investigated. Twenty-five different intact prophages were identified among nineteen MDR E. coli isolates from patient and environments. The most common prophages were Entero_mEp460 which was identified in seven isolates (Two from environment and five from patients) and Entero_BP_4795 (five patient isolates) and Klebsi_4LV2017 (three isolates: two patients and one environmental isolate). P51B from patient and E53 from environment with ST648 had the same phages (Escher_TL_2011b and Klebsi_4LV2017) Supplementary table S6).

The most common integrons were of the class I type identified in sixteen isolates: nine isolates from patients and six from the environment. Similar integrons bearing the same gene cassettes were identified in isolates from both patients and the environment. The integrons commonly encoded genes for sulphamethoxazole, trimethoprim and aminoglycoside resistance. In54 and In191 were the most identified class I integron types, occurring in five and four isolates respectively. Gene cassettes of In54 frequently consisted of AadA5, dfrA17, qacE and sul1. The gene cassettes were common to isolates from four patients and an isolate from the environment. One other isolate from the environment (E50-1) with the In54 differed and lacked the qacE and sul1 genes. The class I integron, In191 which was found with dfrA14 occurred in four isolates from patients and one from the environment (Table 2).

Several different insertion sequences were detected in the E. coli isolates from patients and environments. Twenty isolates harboured at least one insertion sequence element. IS621 was the most commonly occurring insertion element and was found in thirteen isolates (Nine isolates from patients and four from the environment). The insertion sequence MITEEc1 was found in eight (six from patients and two from environments) isolates (Supplementary Table S6).

Table 2 Integrons, gene cassettes (GCs) and sequence types found in the Escherichia coli isolates
Full size table

Virulome, serotypes and phylogroups

Isolates from both patients and environments were found to harbour several virulence genes which did not differ much between sources. The most frequently identified virulence genes included terC which was found in 21 isolates: fourteen from patients and 7 from environment. The virulence gene ipfA was also harboured by 14 isolates – nine from patients and five from environment. Other frequently identified virulence genes in the isolates included, gad (13 isolates), sat (2 isolates), papA (7), irp2 (11), fyuA (11), iutA (7), traT (12), iucC (7), iss (9), yfcv (6), chuA (6), ompT (7). The highest number of virulence genes were found in an isolate P49 from a patient (33 genes) which was acquired on admission. E25B, an isolate from the environment also harboured 25 virulence genes (Table 1).

The somatic (O) and flagellar (H) antigens were used for serotyping the E. coli isolates where twelve different O antigens and 17 different H types were identified across all isolates. No O type was detected for two isolates P73, from patient and E50-1, from environment which only had the H5 and H40 antigens respectively. The O antigen, O101 was common to four isolates (P2R, P105, P159 and P63) from patients. P105 (ST10) and P159 (ST617) had in common, the O101 and H10 antigens. Isolates P128 and P166 both of the novel ST 13,846 had the O15 antigen but varied in the H antigen (Supplementary Table S4). The complexity and diversity of the virulome in isolates from patients and from environments coupled with the range of identified capsule types is a concern for IPC as they are associated with virulence.

Isolates were found to belong to six phylogroups; with six isolates (four carriage isolates and two from environments) belonging to A and to B1. Three isolates (two from patients and one from environments) belonged to the phylogroup F, two isolates each from patients belonged to D and E, while one from a patient and one from environment belonged to the frequently virulent phylogroup B2 and E (Table 1). All phylogroups of patient and environmental isolates harboured several virulence genes.

Sequence types and phylogenomic relationships

MLST analysis showed that the isolates belonged to seventeen different sequence types (ST127, ST73, ST13846, ST1722, ST648, ST617, ST450, ST1638, ST3489, ST10, ST167, ST224, ST410, ST155, ST58, ST5614, ST940). Three isolates (P143, P115 and P63) belonged to unknown STs (Table 1). ST10, ST167, ST225, ST3489, ST617, ST940, ST 13,846 were of community carriage isolates. Two isolates (P73 and P2R) from two patients had the same ST, ST 940. P73 was acquired by a patient on admission. One isolate (P51B) acquired by a patient on admission at the Obstetrics and Gynaecology directorate and one from the environment (E53) of the surgery unit had the same ST 648. Two isolates (P128 and P166) with unknown STs, both isolated from patients in different directorates after 48 h of admission were assigned a putatively novel ST13846. These isolates with same ST showed significant clonal relatedness in the phylogenetic tree (Fig. 1) and had similar resistance genes, virulence genes and plasmids (Table 1). Analyses of the genetic environment of this new ST showed the blaCTX−M−15 and blaTEM−1 genes were associated with Tn3::CTX-M-15:recombinase: TEM-1:IS91(transposase) on a contig which bore close resemblance with the E. coli strain PGR46 plasmid pPGRT46 (KM023153.1). This contig also carried the quinolone resistant gene qnrS1 and the aph(6)-id: aph(3’’)-ib: sul2 genes close to the insertion sequence IS5075 and the Tn3 transposon. P128 and P166 which shared similar resistance genes and genetic environment as P60R (ST1722), differed in the plasmid replicons. P60R, belonging to ST1722 isolated from a patient on admission, with similar resistance genes as P128 and P166 (ST13846) had in addition to the IncY plasmid, IncB/O/K/Z, IncI2(Delta) and pXuzhou21.

Generally, isolates clustered into three main groups with one other grouping of two isolates and an outlier isolate. Group A constituted seven isolates; two isolates (E25B and E53) belonging to ST127 and ST648 from environment and five isolates (P49, P128, P166, P60R and P51B) of STs ST73, ST13846, ST1722 and ST648 from patients. Eight isolates grouped into B and included two isolates (E29 and E56) belonging to ST450 and an unknown ST from environment and six isolates (P63, P143, P159, P165, P105 and P72) belonging to two unknown STs, ST617, ST3489, ST10 and ST167. The third group, C comprised of two isolates (P17 and P142) of STs 224 and ST5617 from patients and three isolates (E37, E50-1 and E55-2) which belonged to ST410, ST155 and ST48 from environments. P2R and P73 both from patients and belonging to ST940 clustered in one group while P115 (unknown ST) was an outlier isolate (Fig. 1).

To visualize the genetic relatedness among E. coli isolates, we inferred a maximum likelihood phylogenetic tree from an alignment of 181 genomes including the complete genome of E. coli K12-MG1655 (reference genome) (Fig. 2). Isolates from this study clustered together with genomes from other countries, frequently with isolates from Nigeria and South Africa. They clustered mainly based on sequence type (Fig. 2). Isolates from the environment, clustered together with isolates of similar sequence types or variants of the sequence types from clinical sources. For instance, E50-1 (ST155), an isolate from the environment clustered together with other isolates of similar ST from clinical sources in other countries (Fig. 2).

Fig. 1
figure 1

The phylogenetic branch and metadata [demographics, molecular typing, and antibiotic resistance genes (ARGs)] coupled by the use of Phandango (https://github.com/jameshadfield/phandango/wiki) in multidrug resistant Escherichia coli isolates (n = 23) from hospital patients and environments in a Teaching Hospital in Ghana

Full size image
Fig. 2
figure 2

Maximum likelihood phylogenetic tree of Escherichia coli strains isolated from humans between 2013 and 2022 in selected African countries. The core-genome phylogenetic tree was drawn from 181 genomes with BV-BRC and annotated with iTOL. The tree was built with E. coli K12-MG1655 as the reference genome and rooted with the reference strain. The following metadata are indicated: the country of isolation on the inner colored ring, the year of isolation in the middle and the MLST in (isolates with unknown STs are indicated U) on the outer ring. Isolates from this study are labelled with green background (isolates from patients) and blue background (isolates from environment)

Full size image

Discussion

This study showed that patients were colonized with genetically diverse ESBL E. coli isolates on admission and during hospital stay. ESBL- producing E. coli strains were also found to be potentially disseminated between patients and their immediate environment.

The carriage of ESBL E. coli isolates by patients on admission in the hospital is suggestive of community carriage and subsequent introduction of these isolates into the directorates of the hospital on admission. Higher carriage rates of ESBL E. coli have been observed in previous studies in Tanzania (23.7%) and Iran (60.0%) [12, 16] and lower rate (10.5%) in Israel [17]. The incidence of ESBL E. coli acquisition among patients who previously did not harbor ESBL E. coli was 11.32%, which is lower than that reported in Israel [17]. Differences in IPC practices and differences in screening time points for ESBL E. coli acquisition in various settings may account for the differences in carriage rates observed. Continuous screening for ESBL E. coli over the course of patients’ stay may contribute to the detection of acquisition events.

Molecular characterization of the MDR E. coli isolated revealed a diversity of resistant genes in both patient carriage and environmental isolates. Among these, the ESBL gene, CTX-M was found predominantly present in the isolates, most likely borne on plasmids and commonly found together with the insertion sequence, IS1380 and the transposase Tn3 which could disseminate this gene between isolates from different sources. The predominance of the blaCTX−M 15 gene has been reported globally and in Ghana, among ESBL E. coli isolates associated with infections of both community and hospital origins [18,19,20]. A study in Libya of clinical E. coli isolates reported a lower rate of 17.3% of isolates carrying the blaCTX−M−15 gene [21] compared to the 52.2% of isolates with the blaCTX−M−15 genes from this study. Though the blaCTX−M gene is frequently associated with the globally disseminated high-risk ST ST131 [22, 23], we found the gene present in E. coli strains with various ST types indicating the successful transfer of the blaCTX−M gene across various strains of E. coli.

There was also marked resistance to ciprofloxacin mediated by chromosomal point mutations in the parCE and gyrAB genes among isolates harbouring the blaCTX−M gene. Fluoroquinolone resistance has often been reported in ESBL-producing E. coli isolates in association with the CTX-M genes [24] raising concerns about the circulation of highly resistant clones. In accordance with other studies, the class 1 integron was present in isolates, together with the CTX-M-15 genes and was found to be associated with genes encoding resistance to aminoglycosides (aadA gene cassettes) and/or trimethoprim (dfrA gene cassettes) [25, 26]. Gene cassettes with sulphonamides (sul1) and quaternary ammonium compounds (qacE) genes) were also found on class 1 integrons that were closely associated with the heavy metal resistance gene, chromium (chrA) resistance gene. The presence of class 1 integrons in both carriage isolates and isolates from environments could facilitate the transfer of resistance genes within and between isolates of different sources as they are noted to disseminate resistance due to their inherent mobility and are important in the development of multidrug resistance in E. coli [27]. Isolates co-bearing the CTX-M-15, qacE and chrA genes in both patient and environmental isolates could co-select for disinfectants, heavy metals and antibiotics [28], becoming problematic in disinfection efforts in IPCs as they are frequently associated with and mobilized by mobile genetic elements, promoting their dissemination.

An interesting finding was the presence of the carbapenemase blaOXA−181 gene in two E. coli isolates of ST940 from patients in the same ward, one of which did not show phenotypic resistance to the carbapenems. Notably, one isolate P73 bearing the blaOXA−181 was acquired on admission by a patient admitted nearly a month after the other patient. The blaOXA−181 gene has been reported among E. coli isolates from colonized patients, but usually among carbapenem resistant isolates, as reported in studies in Kuwait and Korea [29, 30] and recently in E. coli isolates of ST410 and ST940 from paediatric patients with diarrhoea in Ghana [31]]. The contigs that contained the blaOXA−181 gene in both isolates closely resembled the p010_B-OXA181 (CP048332.1) and pEC213_1-OXA-181(CP061102.1) plasmids suggesting a dissemination of an evolving phenotype of the blaOXA−181 gene by same plasmids as reported by Prah et al. [31] in the hospital and in Ghana.

The IncF plasmid was frequently found to be associated with resistant genes in all ST types. Acquired resistance genes in E. coli isolates have been found to be carried by the F plasmids and usually with transposable elements, making the mobilization and dissemination of resistant genes between isolates from various sources possible [32].

The detection of a high number of similar virulence genes in the E. coli isolates from both patient carriage and environment suggests a high pathogenicity of isolates from both community and hospital environments (Table 1). Virulence factors such as the adhesins iha, papA, papC, sfaD, sfaE and sfaS for adherence and invasion, as well as toxins hylA and hylE on virulence genes harboured by the isolates from both patients and environments in this study enable pathogens to survive for longer periods in colonized hosts thereby increasing their chances of eventually causing disease [33]. Coupled with the presence of several virulence genes in the phylogroups A and B1 which were dominant in patient carriage and environmental contamination isolates, there is the potential for increased risk of infection in patients just as isolates of the phylogroups B2 and D which are notably extra-intestinal and virulent [34, 35].

The isolates were found to belong to different STs, of which some were found common to some isolates. Two isolates, from a patient and environment of the same sequence type, ST648 carried similar antibiotic resistance genes, particularly the β-lactamases, blaCTX−M, blaTEM and blaOXA−1 genes (Table 1). These two isolates were also 100% phylogenetically related and interestingly isolated within the same month, from different directorates, i.e. from a patient in the Obstetrics and Gynaecology ward and from a bed in the ICU (Supplementary table S1). The patient had acquired this isolate on admission, suggesting an inter-ward dissemination of the same strain spreading between patients and environment. ST648 E. coli strains, with their biofilm adherence virulence genes have emerged globally as a highly virulent strain likely to cause bacteremia just like the internationally circulating ST131 strain [36] which is first reported among human isolates from Ghana in this study.

Similarly, two isolates from two patients in the Obstetrics and Gynaecology and the Surgical directorates belonged to ST940, one of which was acquired on admission a month after isolation of the other isolate which was carried by a patient into the ward. A novel sequence type ST13846 of the virulent phylogroup D which was detected in two isolates showed high clonal relatedness on phylogenetic analyses. Notably, these isolates were obtained from rectal swabs of two patients in two different directorates, i.e. Obstetrics and Gynaecology and Surgery within the same month and possibly acquired on hospitalization, suggesting a rapid dissemination of this new ST within the hospital. The resistance genes of this new sequence type appeared to be associated with several MGEs which could facilitate the rapid spread of this the antibiotic resistance genes carried by isolates of the new ST within patients in the hospital.

The detection of isolates of common sequence types to patients and in some instances, environment in this study suggests an introduction and subsequent circulation of the ESBL E. coli isolates in the hospital.

Other high-risk STs detected among isolates from patients or environment in this study included ST410, ST1722 and ST10, which have also been observed among E. coli isolates from Ghana [15, 19, 37,38,39]. Phylogenetic analyses of the isolates revealed the clustering of E. coli isolates from patients and environments and in different directorates into similar groups (Fig. 1), suggesting an inter-ward spread of the strains. The clustering of isolates from this study belonging to the high-risk sequence types ST131, ST617, ST648 among others with clinical isolates of same sequence types from other African countries reveals the endemicity of these STs in the Africa. Indeed, these STs have been reported among clinical isolates from infections in Nigeria, Ethiopia and South Africa [40,41,42]. The isolate with novel ST13846 clustered together with strains of ST69, indicating a likelihood of the novel ST being a variant of the ST69 which may have been imported from other African countries. The clustering of isolates colonizing patients and contaminating environments with high-risk clones of clinical isolates from other countries suggest the potential of the isolates from this study to cause clinical infections in patients in the absence of efficient IPCs. There is the need for continuous surveillance for the timely detection of imported antibiotic resistant strains. The isolates were closely related mainly with isolates from Nigeria and South Africa noting that these countries have uploaded the largest number of genomes on the open access databases.

Since rectal screening for ESBLs is not a practice in the hospital, patients who did not consent to screening or did not meet the inclusion criteria could have been missed out as potential sources of acquisition. Environmental surfaces which were not sampled could also have harboured the isolates which were acquired.

This study has revealed the possible dissemination of MDR ESBL-producing E. coli isolates in the hospital between patients and environments, highlighting the necessity of screening patients for carriage of these pathogenic organisms.

This study has also highlighted the importance of using genomic data to detect isolates in patient carriage and environments which may have associations with strains that can cause infections.

Conclusion

MDR ESBL E. coli isolates were found to be circulating among hospitalized patients and their environment in Ghana. These isolates had a repertoire of resistance and virulence genes mainly associated with plasmids making them highly mobile. This is a concern for strengthening IPC practices and surveillance of not only isolates from patients but also from the environment in order to prevent and contain the spread of MDR organisms in hospitals in Ghana.

Data availability

All contiguous sequences have been submitted to GenBank and assigned accession numbers under BioProject PRJNA823741. Other datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

References

  1. Ayukekbong JA, Ntemgwa M, Atabe AN. The threat of antimicrobial resistance in developing countries: causes and control strategies. Antimicrob Resist Infect Control. 2017;6(1):1–8. https://doi.org/10.1186/s13756-017-0208-x

    Article  Google Scholar 

  2. Bassetti M, Peghin M, Vena A, Giacobbe DR. Treatment of infections due to MDR Gram-negative bacteria. Front Med. 2019;6:74. https://doi.org/10.3389/fmed.2019.00074

    Article  Google Scholar 

  3. Braz VS, Melchior K, Moreira CG. Escherichia coli as a multifaceted pathogenic and versatile bacterium. Front Cell Infect Microbiol. 2020;10:548492. https://doi.org/10.3389/fcimb.2020.548492

    Article  PubMed  PubMed Central  Google Scholar 

  4. Fernández-Martínez NF, Cárcel-Fernández S, la Fuente-Martos D, Ruiz-Montero R, Guzmán-Herrador BR, León-López R, et al. Emerging microbes & infections. Int J Environ Res Public Health. 2022;19(3):1039. https://doi.org/10.3390/ijerph19031039

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Bezabih YM, Sabiiti W, Alamneh E, Bezabih A, Peterson GM, Bezabhe WM, et al. The global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli in the community. J Antimicrob Chemother. 2021;76(1):22–9. https://doi.org/10.1093/jac/dkaa399

    Article  CAS  PubMed  Google Scholar 

  6. Runcharoen C, Raven KE, Reuter S, Kallonen T, Paksanont S, Thammachote J, et al. Whole genome sequencing of ESBL-producing Escherichia coli isolated from patients, farm waste and canals in Thailand. Genome Med. 2017;9(1):1–11. https://doi.org/10.1186/s13073-017-0471-8

    Article  CAS  Google Scholar 

  7. Poirel L, Madec J-Y, Lupo A, Schink A-K, Kieffer N, Nordmann P, et al. Antimicrobial resistance in Escherichia coli. Microbiol Spectr. 2018;6(4):6–4. https://doi.org/10.1128/microbiolspec.arba-0026-2017

    Article  Google Scholar 

  8. Sarowska J, Futoma-Koloch B, Jama-Kmiecik A, Frej-Madrzak M, Ksiazczyk M, Bugla-Ploskonska G, et al. Virulence factors, prevalence and potential transmission of extraintestinal pathogenic Escherichia coli isolated from different sources: recent reports. Gut Pathog. 2019;11(1):1–16. https://doi.org/10.1186/s13099-019-0290-0

    Article  Google Scholar 

  9. World Health Organization. WHO publishes list of bacteria for which new antibiotics are urgently needed. (2017). http://www.who.int/mediacentre/news/releases/2017/bacteria-antibiotics-needed/en/. Accessed 20 May, 2023.

  10. Biehl LM, Schmidt-Hieber M, Liss B, Cornely OA, Vehreschild MJ. Colonization and infection with extended spectrum beta-lactamase producing Enterobacteriaceae in high-risk patients–review of the literature from a clinical perspective. Crit Rev Microbiol. 2016;42(1):1–16. https://doi.org/10.3109/1040841X.2013.875515

    Article  CAS  PubMed  Google Scholar 

  11. Ogunbosi BO, Moodley C, Naicker P, Nuttall J, Bamford C, Eley B. Colonisation with extended spectrum beta-lactamase-producing and carbapenem-resistant enterobacterales in children admitted to a paediatric referral hospital in South Africa. PLoS ONE. 2020;15(11):e0241776. https://doi.org/10.1371/journal.pone.0241776

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Moremi N, Claus H, Rutta L, Frosch M, Vogel U, Mshana S. High carriage rate of extended-spectrum beta-lactamase-producing Enterobacteriaceae among patients admitted for surgery in Tanzanian hospitals with a low rate of endogenous surgical site infections. J Hosp Infect. 2018;100(1):47–53. https://doi.org/10.1016/j.jhin.2018.05.017

    Article  CAS  PubMed  Google Scholar 

  13. Dela H, Egyir B, Majekodunmi AO, Behene E, Yeboah C, Ackah D, Diarrhoeagenic E, et al. Coli occurrence and antimicrobial resistance of Extended Spectrum Beta-Lactamases isolated from diarrhoea patients attending health facilities in Accra, Ghana. PLoS ONE. 2022;17(5):e0268991. https://doi.org/10.1371/journal.pone.0268991

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Mahazu S, Prah I, Ayibieke A, Sato W, Hayashi T, Suzuki T, et al. Possible dissemination of E. Coli sequence type 410 closely related to B4/H24RxC in Ghana. Front Microbiol. 2021;3673. https://doi.org/10.3389/fmicb.2021.770130

  15. Asare Yeboah EE, Agyepong N, Mbanga J, Amoako DG, Abia AL, Owusu-Ofori A, Essack SY. Multidrug-resistant Gram-negative bacterial colonization in patients, carriage by healthcare workers and contamination of hospital environments in Ghana. J Infect Public Health. 2023;1(16):2–8. https://doi.org/10.1016/j.jiph.2023.10.045

    Article  Google Scholar 

  16. Aghamohammad S, Badmasti F, Shirazi AS, Dabiri H, Solgi H, Sabeti S, Shahcheraghi F. Considerable rate of putative virulent phylo-groups in fecal carriage of extended-spectrum β-lactamase producing Escherichia coli. Infect Genet Evol. 2019;1(73):184–9. https://doi.org/10.1016/j.meegid.2019.04.035

    Article  CAS  Google Scholar 

  17. Adler A, Gniadkowski M, Baraniak A, Izdebski R, Fiett J, Hryniewicz W, Malhotra-Kumar S, Goossens H, Lammens C, Lerman Y, Kazma M. Transmission dynamics of ESBL-producing Escherichia coli clones in rehabilitation wards at a tertiary care centre. Clin Microbiol Infect. 2012;18(12):E497–505. https://doi.org/10.1111/j.1469-0691.2012.03999.x

    Article  CAS  PubMed  Google Scholar 

  18. Mahazu S, Sato W, Ayibieke A, Prah I, Hayashi T, Suzuki T, et al. Insights and genetic features of extended-spectrum beta-lactamase producing Escherichia coli isolates from two hospitals in Ghana. Sci Rep. 2022;12(1):1–11. https://doi.org/10.1038/s41598-022-05869-6

    Article  CAS  Google Scholar 

  19. Falgenhauer L, Imirzalioglu C, Oppong K, Akenten CW, Hogan B, Krumkamp R, et al. Detection and characterization of ESBL-producing Escherichia coli from humans and poultry in Ghana. Front Microbiol. 2019;9:3358. https://doi.org/10.3389/fmicb.2018.03358

    Article  PubMed  PubMed Central  Google Scholar 

  20. Zorgani A, Almagatef A, Sufya N, Bashein A, Tubbal A. Detection of CTX-M-15 among uropathogenic Escherichia coli isolated from five major hospitals in Tripoli, Libya. Oman Med J. 2017;32(4):322–7. https://doi.org/10.5001/omj.2017.61

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Aibinu I, Odugbemi T, Koenig W, Ghebremedhin B. Sequence type ST131 and ST10 complex (ST617) predominant among CTX-M-15-producing Escherichia coli isolates from Nigeria. Clin Microbiol Infect. 2012;18(3):E49–51. https://doi.org/10.1111/j.1469-0691.2011.03730.x

    Article  CAS  PubMed  Google Scholar 

  22. Dziri R, Klibi N, Alonso CA, Jouini A, Ben Said L, Chairat S, et al. Detection of CTX-M-15-producing Escherichia coli isolates of lineages ST131-B2 and ST167-A in environmental samples of a Tunisian hospital. Microb Drug Resist. 2016;22(5):399–403. https://doi.org/10.1089/mdr.2015.0354

    Article  CAS  PubMed  Google Scholar 

  23. Merino I, Hernández-García M, Turrientes M-C, Pérez-Viso B, López-Fresneña N, Diaz-Agero C, et al. Emergence of ESBL-producing Escherichia coli ST131-C1-M27 clade colonizing patients in Europe. J Antimicrob Chemother. 2018;73(11):2973–80. https://doi.org/10.1093/jac/dky296

    Article  CAS  PubMed  Google Scholar 

  24. Johnson JR, Urban C, Weissman SJ, Jorgensen JH, Lewis JS, Hansen G, et al. Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25: H4) and bla CTX-M-15 among extended-spectrum-β-lactamase-producing E. Coli from the United States, 2000 to 2009. Antimicrob Agents Chemother. 2012;56(5):2364–70. https://doi.org/10.1128/aac.05824-11

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Oliveira-Pinto C, Diamantino C, Oliveira PL, Reis MP, Costa PS, Paiva MC, et al. Occurrence and characterization of class 1 integrons in Escherichia coli from healthy individuals and those with urinary infection. J Med Microbiol. 2017;66(5):577–83. https://doi.org/10.1099/jmm.0.000468

    Article  CAS  PubMed  Google Scholar 

  26. Li W, Ma J, Sun X, Liu M, Wang H. Antimicrobial Resistance and Molecular characterization of Gene cassettes from Class 1 Integrons in Escherichia coli strains. Microb Drug Resist. 2022;28(4):413–8. https://doi.org/10.1089/mdr.2021.0172

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Sabbagh P, Rajabnia M, Maali A, Ferdosi-Shahandashti E. Integron and its role in antimicrobial resistance: a literature review on some bacterial pathogens. Iran J Basic Med Sci. 2021;24(2):136. https://doi.org/10.22038/ijbms.2020.48905.11208.

    PubMed  PubMed Central  Google Scholar 

  28. Yang S, Deng W, Liu S, Yu X, Mustafa GR, Chen S, He L, Ao X, Yang Y, Zhou K, Li B. Presence of heavy metal resistance genes in Escherichia coli and Salmonella isolates and analysis of resistance gene structure in E. Coli E308. J Glob Antimicrob Resist. 2020;1(21):420–6. https://doi.org/10.1016/j.jgar.2020.01.009

    Article  Google Scholar 

  29. Al Fadhli AH, Jamal WY, Rotimi VO. Prevalence of carbapenem-resistant Enterobacteriaceae and emergence of high rectal colonization rates of bla OXA-181-positive isolates in patients admitted to two major hospital intensive care units in Kuwait. PLoS ONE. 2020;15(11):e0241971. https://doi.org/10.1371/journal.pone.0241971

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Kim JS, Yu JK, Jeon SJ, Park S-H, Han S, Park SH, et al. Dissemination of an international high-risk clone of Escherichia coli ST410 co-producing NDM-5 and OXA-181 carbapenemases in Seoul, Republic of Korea. Int J Antimicrob Agents. 2021;58(6):106448. https://doi.org/10.1016/j.ijantimicag.2021.106448

    Article  CAS  PubMed  Google Scholar 

  31. Prah I, Ayibieke A, Mahazu S, Sassa CT, Hayashi T, Yamaoka S, et al. Emergence of oxacillinase-181 carbapenemase-producing diarrheagenic Escherichia coli in Ghana. Emerg Microbes Infect. 2021;10(1):865–73. https://doi.org/10.1080/22221751.2021.1920342

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Stephens C, Arismendi T, Wright M, Hartman A, Gonzalez A, Gill M, et al. F plasmids are the major carriers of antibiotic resistance genes in human-associated commensal Escherichia coli. Msphere. 2020;5(4):e00709–20. https://doi.org/10.1128/msphere.00709-20

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Dadi BR, Abebe T, Zhang L, Mihret A, Abebe W, Amogne W. Distribution of virulence genes and phylogenetics of uropathogenic Escherichia coli among urinary tract infection patients in Addis Ababa, Ethiopia. BMC Infect Dis. 2020;20:1–12. https://doi.org/10.1186/s12879-020-4844-z

    Article  CAS  Google Scholar 

  34. Ouchar Mahamat O, Tidjani A, Lounnas M, Hide M, Benavides J, Somasse C, et al. Fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in hospital and community settings in Chad. Antimicrob Resist Infect Control. 2019;8(1):1–7. https://doi.org/10.1186/s13756-019-0626-z

    Article  Google Scholar 

  35. Vading M, Kabir M, Kalin M, Iversen A, Wiklund S, Nauclér P, et al. Frequent acquisition of low-virulence strains of ESBL-producing Escherichia coli in travellers. J Antimicrob Chemother. 2016;71(12):3548–55. https://doi.org/10.1093/jac/dkw335

    Article  CAS  PubMed  Google Scholar 

  36. Schaufler K, Semmler T, Wieler LH, Trott DJ, Pitout J, Peirano G, et al. Genomic and functional analysis of emerging virulent and multidrug-resistant Escherichia coli lineage sequence type 648. Antimicrob Agents Chemother. 2019;63(6):e00243–19. https://doi.org/10.1128/aac.00243-19

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Prah I, Ayibieke A, Nguyen TTH, Iguchi A, Mahazu S, Sato W, et al. Virulence profiles of Diarrheagenic Escherichia coli isolated from the Western Region of Ghana. Jpn J Infect Dis. 2021;74(2):115–21. https://doi.org/10.7883/yoken.jjid.2020.356

    Article  CAS  PubMed  Google Scholar 

  38. Eibach D, Dekker D, Boahen KG, Akenten CW, Sarpong N, Campos CB, et al. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in local and imported poultry meat in Ghana. Vet Microbiol. 2018;217:7–12. https://doi.org/10.1016/j.vetmic.2018.02.023

    Article  PubMed  Google Scholar 

  39. Founou LL, Founou RC, Allam M, Ismail A, Essack SY. Genome analysis of ESBL-producing Escherichia coli isolated from pigs. Pathogens. 2022;11(7):776. https://doi.org/10.3390/pathogens11070776

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Jesumirhewe C, Springer B, Allerberger F, Ruppitsch W. Whole genome sequencing of extended-spectrum β-lactamase genes in Enterobacteriaceae isolates from Nigeria. PLoS ONE. 2020;15(4):e0231146. https://doi.org/10.1371/journal.pone.0231146

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Sewunet T, Asrat D, Woldeamanuel Y, Ny S, Westerlund F, Aseffa A, et al. High prevalence of bla CTX-M-15 and nosocomial transmission of hypervirulent epidemic clones of Klebsiella pneumoniae at a tertiary hospital in Ethiopia. JAC Antimicrob Resist. 2021;3(1):dlab001. https://doi.org/10.1093/jacamr/dlab001

    Article  PubMed  PubMed Central  Google Scholar 

  42. Mbelle NM, Feldman C, Osei Sekyere J, Maningi NE, Modipane L, Essack SY. The resistome, mobilome, virulome and phylogenomics of multidrug-resistant Escherichia coli clinical isolates from Pretoria, South Africa. Sci Rep. 2019;9(1):16457. https://doi.org/10.1038/s41598-019-52859-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We are grateful to the Sequencing Core Facility, National Institute for Communicable Diseases, Johannesburg, South Africa. We are also grateful to patients and staff at the Obstetrics and Gynaecology Directorate, Surgery and Intensive Care Units of the Komfo Anokye Teaching Hospital who participated in this study. We thank research assistants (nurses, biomedical scientists and biostatisticians) at the study sites, the Head of Departments and staff at the various directorates and the microbiology laboratory, Komfo Anokye Teaching Hospital and staff of for their support during the study.

Funding

This study was supported by South African Research Chair Initiative of the Department of Science and Technology and National Research Foundation of South Africa (Grant No. 98342) and the L’Oréal UNESCO For Women in Science Fellowship. The funding sources had no influence on the study design, data collection, analysis, interpretation of the data, or the writing of the manuscript.

Author information

Authors and Affiliations

  1. Antimicrobial Research Unit, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa

    Esther Eyram Asare Yeboah, Joshua Mbanga, Daniel Gyamfi Amoako, Akebe Luther King Abia & Sabiha Yusuf Essack

  2. Department of Pharmaceutical Sciences, School of Pharmacy, Central University, P.O.Box 2305, Miotso, Ghana

    Esther Eyram Asare Yeboah

  3. Department of Pharmaceutical Sciences, Sunyani Technical University, Sunyani, Ghana

    Nicholas Agyepong

  4. Department of Applied Biology & Biochemistry, National University of Science and Technology, P Bag AC939, Bulawayo, Zimbabwe

    Joshua Mbanga

  5. Department of Integrative Biology and Bioinformatics, University of Guelph, Guelph, ON, Canada

    Daniel Gyamfi Amoako

  6. Environmental Research Foundation, Westville, 3630, South Africa

    Akebe Luther King Abia

  7. Sequencing Core Facility, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, 2131, South Africa

    Arshad Ismail

  8. Department of Biochemistry and Microbiology, Faculty of Science, Engineering and Agriculture, University of Venda, Tohoyandou, 0950, South Africa

    Arshad Ismail

  9. Department of Clinical Microbiology, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana

    Alexander Owusu-Ofori

  10. Clinical Microbiology Unit, Laboratory Services Directorate, Komfo Anokye Teaching Hospital, Kumasi, Ghana

    Alexander Owusu-Ofori

Authors
  1. Esther Eyram Asare Yeboah
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nicholas Agyepong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Joshua Mbanga
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Daniel Gyamfi Amoako
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Akebe Luther King Abia
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Arshad Ismail
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Alexander Owusu-Ofori
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Sabiha Yusuf Essack
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

EEAY, NA, AOO and SYE co-conceptualized the study. EEAY undertook sample collection, laboratory and statistical analyses and wrote the original draft of the manuscript. EEAY, JM, DGA, ALKA and AI conducted data analysis. SYE, AOO, NA, ALKA, AI, DGA and JM supervised the work, vetted the results and critically reviewed the manuscript. All authors (EEAY, JM, NA, DGA, ALKA, AI, AOO and SYE) read and approved the manuscript.

Corresponding author

Correspondence to Esther Eyram Asare Yeboah.

Ethics declarations

Ethical approval and consent to participate

The study was approved by the Institutional Review board (IRB) of the KATH (Reference: KATH IRB/AP/107/20) and the Biomedical Research Ethics Committee of the University of KwaZulu-Natal (Reference: BREC/00001917/2020). Voluntary, informed written consent was obtained from participating patients and staff.

Consent for publication

Voluntary, informed written consent for publication of findings from the study was obtained from participating patients and staff.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Asare Yeboah, E.E., Agyepong, N., Mbanga, J. et al. Genomic characterization of multi drug resistant ESBL-producing Escherichia coli isolates from patients and patient environments in a teaching hospital in Ghana. BMC Microbiol 24, 250 (2024). https://doi.org/10.1186/s12866-024-03406-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12866-024-03406-1

Keywords

BMC Microbiology

ISSN: 1471-2180

Contact us